Aleeto
- Generic Name
- Aleeto
The Study of Safety and Preliminary Efficacy of Aleeto in Patients with MultIple System Atrophy
Early Phase 1
Not yet recruiting
- Conditions
- Multiple System Atrophy - Parkinsonian Subtype (MSA-P)Multiple System Atrophy, MSA
- Interventions
- First Posted Date
- 2025-01-09
- Last Posted Date
- 2025-01-09
- Lead Sponsor
- Beijing Tiantan Hospital
- Target Recruit Count
- 20
- Registration Number
- NCT06765733
- Locations
- 🇨🇳
Beijing Tiantan Hospital, Capital Medical University, Beijing, Beijing, China
Aleeto in Acute ISchemic Stroke：A RandomISed Controlled Clinical Trial
- First Posted Date
- 2025-01-06
- Last Posted Date
- 2025-02-28
- Lead Sponsor
- Beijing Tiantan Hospital
- Target Recruit Count
- 192
- Registration Number
- NCT06759753
- Locations
- 🇨🇳
Beijing Tiantan Hospital, Beijing, China
Safety and Preliminary Efficacy of Aleeto in Amyotrophic Lateral Sclerosis
Phase 1
Not yet recruiting
- Conditions
- Amyotrophic Lateral Sclerosis
- Interventions
- First Posted Date
- 2023-12-26
- Last Posted Date
- 2023-12-26
- Lead Sponsor
- Beijing Tiantan Hospital
- Target Recruit Count
- 24
- Registration Number
- NCT06181526
- Locations
- 🇨🇳
Beijing Tiantan Hospital, Beijing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath